Ignite Creation Date:
2024-07-17 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06462469
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2024-06-05
Brief Title:
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs Host Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis